治疗药物-话题@MedSci

#治疗药物#

300篇内容 | 2624人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1921772, encodeId=6f0f1921e7229, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Y-mAbs在美国申请将抗GD2单抗naxitamab批准用作神经母细胞瘤的突破性治疗药物, objectType=article, longId=184091, objectId=ac6c18409105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac6c18409105, replyNumber=0, likeNumber=68, createdTime=2020-08-23, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac6c18409105, moduleTitle=Y-mAbs在美国申请将抗GD2单抗naxitamab批准用作神经母细胞瘤的突破性治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac6c18409105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921746, encodeId=5d681921e461d, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=高血压治疗药物依从性的测量方法学, objectType=article, longId=165209, objectId=13671652094d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13671652094d, replyNumber=0, likeNumber=74, createdTime=2019-10-09, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13671652094d, moduleTitle=高血压治疗药物依从性的测量方法学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13671652094d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921761, encodeId=227a1921e61c0, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, objectType=article, longId=178850, objectId=de591e885009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de591e885009, replyNumber=0, likeNumber=57, createdTime=2020-04-09, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de591e885009, moduleTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de591e885009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921740, encodeId=5fa01921e40fe, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, objectType=article, longId=164214, objectId=c97916421410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97916421410, replyNumber=0, likeNumber=60, createdTime=2020-03-19, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97916421410, moduleTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c97916421410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921747, encodeId=fa591921e4764, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Met Eng：华理研究成果有望降低高血脂治疗药物生产成本, objectType=article, longId=166132, objectId=5063166132be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5063166132be, replyNumber=0, likeNumber=55, createdTime=2019-09-10, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5063166132be, moduleTitle=Met Eng：华理研究成果有望降低高血脂治疗药物生产成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5063166132be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921744, encodeId=a2d11921e4400, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=研究证实，慢阻肺维持治疗药物乌美溴铵/维兰特罗有效改善肺功能, objectType=article, longId=165000, objectId=16e11650002d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e11650002d, replyNumber=0, likeNumber=78, createdTime=2019-12-13, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e11650002d, moduleTitle=研究证实，慢阻肺维持治疗药物乌美溴铵/维兰特罗有效改善肺功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e11650002d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921755, encodeId=c47e1921e55f6, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=阿尔茨海默症治疗药物的研发仍在前赴后继：Tau抑制剂ACI-3024的I期临床正式开始, objectType=article, longId=175767, objectId=e79f1e57677e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e79f1e57677e, replyNumber=0, likeNumber=71, createdTime=2020-04-17, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e79f1e57677e, moduleTitle=阿尔茨海默症治疗药物的研发仍在前赴后继：Tau抑制剂ACI-3024的I期临床正式开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e79f1e57677e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921779, encodeId=f23d1921e79e2, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=礼来的REYVOW作为**种也是唯一的新型偏头痛急性治疗药物，现在美国已可用于开处方, objectType=article, longId=187158, objectId=26d818e15898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26d818e15898, replyNumber=0, likeNumber=76, createdTime=2020-08-07, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26d818e15898, moduleTitle=礼来的REYVOW作为**种也是唯一的新型偏头痛急性治疗药物，现在美国已可用于开处方, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26d818e15898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921758, encodeId=a3031921e58a0, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Daiichi Sankyo的Turalio成为FDA批准的腱鞘巨细胞瘤治疗药物, objectType=article, longId=176954, objectId=78dc1e695499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78dc1e695499, replyNumber=0, likeNumber=79, createdTime=2019-12-24, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78dc1e695499, moduleTitle=Daiichi Sankyo的Turalio成为FDA批准的腱鞘巨细胞瘤治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78dc1e695499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921760, encodeId=9b9d1921e6045, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Harmony Biosciences的嗜睡症治疗药物Wakix获得FDA批准, objectType=article, longId=177799, objectId=8b831e7799a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b831e7799a0, replyNumber=0, likeNumber=50, createdTime=2020-07-25, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b831e7799a0, moduleTitle=Harmony Biosciences的嗜睡症治疗药物Wakix获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b831e7799a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921737, encodeId=a7061921e3721, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=EBioMedicine：前列腺癌治疗药物新发现, objectType=article, longId=163701, objectId=ce94163e01ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce94163e01ab, replyNumber=0, likeNumber=95, createdTime=2019-05-28, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce94163e01ab, moduleTitle=EBioMedicine：前列腺癌治疗药物新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce94163e01ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921745, encodeId=b7dc1921e456a, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=全球脊髓性肌萎缩症治疗药物诺西那生钠注射液正式在中国上市, objectType=article, longId=165177, objectId=71331651e715, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71331651e715, replyNumber=0, likeNumber=60, createdTime=2019-10-19, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71331651e715, moduleTitle=全球脊髓性肌萎缩症治疗药物诺西那生钠注射液正式在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71331651e715)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921770, encodeId=e8751921e7042, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物, objectType=article, longId=183110, objectId=78d91831105f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d91831105f, replyNumber=0, likeNumber=71, createdTime=2020-09-30, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d91831105f, moduleTitle=复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d91831105f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921753, encodeId=4bea1921e5371, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物, objectType=article, longId=168259, objectId=eaa316825915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaa316825915, replyNumber=0, likeNumber=71, createdTime=2020-04-06, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaa316825915, moduleTitle=上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaa316825915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921763, encodeId=238f1921e6358, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=针对广泛期小细胞肺癌，免疫治疗药物Imfinzi显著改善生存获益和持久疗效, objectType=article, longId=179249, objectId=c3431e924935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3431e924935, replyNumber=0, likeNumber=62, createdTime=2019-11-22, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3431e924935, moduleTitle=针对广泛期小细胞肺癌，免疫治疗药物Imfinzi显著改善生存获益和持久疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3431e924935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921767, encodeId=3d8a1921e6794, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案, objectType=article, longId=181799, objectId=6cee181e9981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cee181e9981, replyNumber=0, likeNumber=87, createdTime=2019-12-06, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cee181e9981, moduleTitle=Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cee181e9981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921742, encodeId=bf061921e4221, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=420高尿酸日：来了解下常用痛风治疗药物的副作用 | 用药知识, objectType=article, longId=164643, objectId=4f8016464358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8016464358, replyNumber=0, likeNumber=99, createdTime=2019-06-12, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8016464358, moduleTitle=420高尿酸日：来了解下常用痛风治疗药物的副作用 | 用药知识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8016464358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921754, encodeId=36971921e54a1, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=ViiV的双药治疗药物Dovato获得欧盟批准用于治疗艾滋病, objectType=article, longId=174801, objectId=d4cc1e480193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4cc1e480193, replyNumber=0, likeNumber=79, createdTime=2019-12-07, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4cc1e480193, moduleTitle=ViiV的双药治疗药物Dovato获得欧盟批准用于治疗艾滋病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4cc1e480193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921762, encodeId=484c1921e625f, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=帕金森双重治疗药物康复训练, objectType=article, longId=178976, objectId=3bc71e8976a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc71e8976a7, replyNumber=0, likeNumber=81, createdTime=2020-08-18, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc71e8976a7, moduleTitle=帕金森双重治疗药物康复训练, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc71e8976a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921748, encodeId=4c4c1921e48fe, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept, objectType=article, longId=166454, objectId=6ee2166454fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ee2166454fd, replyNumber=0, likeNumber=84, createdTime=2019-08-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ee2166454fd, moduleTitle=Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ee2166454fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗药物

2020-05-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Y-mAbs在美国申请将抗GD2单抗naxitamab批准用作神经母细胞瘤的突破性治疗药物

2020-08-23

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

高血压治疗药物依从性的测量方法学

2019-10-09

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物

2020-04-09

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批

2020-03-19

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Met Eng：华理研究成果有望降低高血脂治疗药物生产成本

2019-09-10

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

研究证实，慢阻肺维持治疗药物乌美溴铵/维兰特罗有效改善肺功能

2019-12-13

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

阿尔茨海默症治疗药物的研发仍在前赴后继：Tau抑制剂ACI-3024的I期临床正式开始

2020-04-17

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

礼来的REYVOW作为**种也是唯一的新型偏头痛急性治疗药物，现在美国已可用于开处方

2020-08-07

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Daiichi Sankyo的Turalio成为FDA批准的腱鞘巨细胞瘤治疗药物

2019-12-24

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Harmony Biosciences的嗜睡症治疗药物Wakix获得FDA批准

2020-07-25

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

EBioMedicine：前列腺癌治疗药物新发现

2019-05-28

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

全球脊髓性肌萎缩症治疗药物诺西那生钠注射液正式在中国上市

2019-10-19

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物

2020-09-30

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物

2020-04-06

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

针对广泛期小细胞肺癌，免疫治疗药物Imfinzi显著改善生存获益和持久疗效

2019-11-22

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案

2019-12-06

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

420高尿酸日：来了解下常用痛风治疗药物的副作用 | 用药知识

2019-06-12

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

ViiV的双药治疗药物Dovato获得欧盟批准用于治疗艾滋病

2019-12-07

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

帕金森双重治疗药物康复训练

2020-08-18

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept

2019-08-01

科室
- - 订阅+
  - 更多科室
工具
服务